Evidence map›Paper›PMID 28246950›Full record

ArticleMagma (New York, N.Y.)2017

Biomarkers from in vivo molecular imaging of breast cancer: pretreatment

Francesca Gallivanone, Marta Maria Panzeri, Carla Canevari, Claudio Losio, Luigi Gianolli, Francesco De Cobelli, Isabella Castiglioni

Open access · hybridAbstract read
In one paragraph

Article in Magma (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Hybrid [Bioengineering (Basel, Switzerland) · 2026
    Article
  3. Baseline [European journal of nuclear medicine and molecular imaging · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Francesca GallivanoneInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via Fratelli Cervi 93, Segrate, 20090, Milan, Italy.
Marta Maria PanzeriDepartment of Radiology, Centre for Experimental Imaging, San Raffaele Scientific Institute, Milan, Italy.
Carla CanevariDepartment of Nuclear Medicine, Centre for Experimental Imaging, San Raffaele Scientific Institute, Milan, Italy.
Claudio LosioDepartment of Radiology, Centre for Experimental Imaging, San Raffaele Scientific Institute, Milan, Italy.
Luigi GianolliDepartment of Nuclear Medicine, Centre for Experimental Imaging, San Raffaele Scientific Institute, Milan, Italy.
Francesco De CobelliDepartment of Radiology, Centre for Experimental Imaging, San Raffaele Scientific Institute, Milan, Italy.
Isabella CastiglioniInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via Fratelli Cervi 93, Segrate, 20090, Milan, Italy. isabella.castiglioni@ibfm.cnr.it.
San Raffaele University of Rome · ITInstitute of Molecular Bioimaging and Physiology · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHuman cancers display intra-tumor phenotypic heterogeneity and recent research has focused on developing image processing methods extracting imaging descriptors to characterize this heterogeneity. This work assesses the role of pretreatment MATERIALS AND

methodsA retrospective protocol included 38 adult women with biopsy-proven BC. Patients underwent a pre-therapy

resultsOur work demonstrates that macroscopic and histogram features from

conclusionOur work suggests that pre-treatment

Indexed as

AdultAgedBiomarkers, TumorBreast NeoplasmsChemotherapy, AdjuvantDiffusion Magnetic Resonance ImagingFemaleFluorodeoxyglucose F18HumansMiddle AgedMolecular ImagingNeoadjuvant TherapyPositron Emission Tomography Computed TomographyPrognosisRadiopharmaceuticalsRetrospective StudiesBiomarkers, TumorFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTBreast cancerDWI-MRIImage features

Identifiers

PMID28246950
PMCPMC5524876
OpenAlexW2593401308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.